ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Conversion from Twice Daily to Once Daily Tacrolimus Improves Adherence in Kidney Transplant Recipients.

M. Levine,1 K. Wen.2

1Division of Urology, University of Alberta, Edmonton, AB, Canada
2Department of Nephrology, University of Alberta, Edmonton, AB, Canada

Meeting: 2017 American Transplant Congress

Abstract number: D73

Keywords: Immunosuppression, Kidney transplantation

Session Information

Session Name: Poster Session D: Kidney Immunosuppression: Novel Regimens and Drug Minimization

Session Type: Poster Session

Date: Tuesday, May 2, 2017

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall D1

INTRODUCITON AND OBJECTIVE: Kidney transplant longevity is largely related to immunosuppressive efficacy, which is highly dependent on patient adherence. Drug dosing frequency is one way the prescriber can influence adherence. The objective of this study is to determine if conversion from twice to once daily tacrolimus improves medication adherence in kidney transplant recipients.

METHODS: This is a retrospective cohort study examining kidney transplant recipients at our institution transplanted between 2005-2014 who were prescribed twice daily tacrolimus and subsequently converted to once daily formulations. The primary outcome is the rate of adherence to tacrolimus. Adherence was assessed by review of pharmacy prescription fill data and calculation of the cumulative days lapsed between refills, expressed as the percentage medication missed days (PMD): a positive value indicated days lapsed between refills while a negative value indicated refills picked up prior to the end of the previous prescription duration indicating adequate supply of medication. Patients were subdivided into tertiles of PMD on twice daily dosing and compared to post-conversion PMD within tertiles. Statistical analysis included two-tailed paired t-test for comparison of adherence rates, and Chi-square analysis of the distribution of donor types, with an alpha of 0.05.

RESULTS: A total of 203 patients met inclusion criteria for analysis. The mean age was 46.5 (SD 15.1) years (2-80 years). The average PMD while on twice daily dosing was -5.3% and while on daily dosing was -9.2% (p=0.13). When patients were subsequently divided into tertiles based on their PMD on twice daily tacrolimus, the first tertile showed worsening of adherence after conversion from twice daily to daily dosing (-30.2% to -10.6%, p <0.001) but clinically remained “adherent”. The second tertile did not significantly change after conversion to (-5 to -10%, p = 0.07). The third tertile showed significant improvement in adherence, both statistically and clinically, after conversion to daily dosing (+23% to -7%, p < 0.001).

CONCLUSIONS: The conversion to once daily tacrolimus has the potential to significantly improve adherence in a subset of the kidney transplant population. Those with the worst adherence (3rd tertile of PMD) show the greatest improvement with a reduced frequency of medications while those with good baseline adherence on twice daily dosing remain adherent after conversion.

CITATION INFORMATION: Levine M, Wen K. Conversion from Twice Daily to Once Daily Tacrolimus Improves Adherence in Kidney Transplant Recipients. Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Levine M, Wen K. Conversion from Twice Daily to Once Daily Tacrolimus Improves Adherence in Kidney Transplant Recipients. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/conversion-from-twice-daily-to-once-daily-tacrolimus-improves-adherence-in-kidney-transplant-recipients/. Accessed June 2, 2025.

« Back to 2017 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences